Micro Emerging Active

Rapport Therapeutics price target raised

New narrative with limited coverage — still forming.

Score
0.2
Velocity
▲ 0.0
Articles
2
Sources
1

Sentiment Timeline

Event Timeline

Jun 16, 2026
Is Rapport Therapeutics, Inc. (RAPP) A Good Stock To Buy Now? Bullish
Jun 07, 2026
BTIG Raises its Price Target on Rapport Therapeutics (RAPP) Neutral

Related Articles

BTIG Raises its Price Target on Rapport Therapeutics (RAPP)

Yahoo Finance · Jun 07, 2026
Bearish

Timeline

Last UpdatedJun 07, 2026